CounterAct Night is a Oral Tablet, Coated in the Human Otc Drug category. It is labeled and distributed by Melaleuca, Inc.. The primary component is Acetaminophen; Diphenhydramine Hydrochloride; Phenylephrine Hydrochloride.
Product ID | 54473-184_65e96c30-97cd-7b1f-e053-2991aa0aa9ea |
NDC | 54473-184 |
Product Type | Human Otc Drug |
Proprietary Name | CounterAct Night |
Generic Name | Acetaminophen, Diphenydramine Hci, Phenylephrine Hci |
Dosage Form | Tablet, Coated |
Route of Administration | ORAL |
Marketing Start Date | 2011-08-01 |
Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
Application Number | part341 |
Labeler Name | Melaleuca, Inc. |
Substance Name | ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE |
Active Ingredient Strength | 325 mg/1; mg/1; mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2018-01-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC monograph final |
Application Number | part341 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2018-02-23 |
Marketing End Date | 2019-12-31 |
Marketing Category | OTC monograph final |
Application Number | part341 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2018-01-01 |
Marketing End Date | 2019-12-31 |
Ingredient | Strength |
---|---|
ACETAMINOPHEN | 325 mg/1 |
SPL SET ID: | c500f07b-1a07-4afb-a98c-4a8ee9e16675 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |